looking into to different ways nanotechnology can be used and in turn Anteotech future markets. just a snippet of one article I've seen lately
View attachment 6497460
the nanotechnology market is in a sweet spot at the moment and just look at how anteotech's chemistry has moved into different markets lately.
in our CET division it started with an binder additive - anteoX, then a complete 70% silicon anode Ultranode (just on that, seeing that industry is working on 10-20% silicon anodes, how confident are Manuel and the team that they jumped over 30%, 40%, 50%, 60% straight to 70% !!! Hmmmm) then working with nanotubes and then separators. when will we start working on cathodes?
had these published recently for anteobind use, just some of many
View attachment 6497478
View attachment 6497481
a study from a collection of Indian universities
View attachment 6497490
"To immobilize the bioreceptor, SA aldolase, a bioaffinity layer (BAL) or activation reagent
AnteoBind was used."
then this
View attachment 6497493
being involved in the ARC program
View attachment 6497529
Bioconjugation of polymer coated UCNPs with anti- nucleoprotein monoclonal antibody (UCNPs@mAb)
The bioconjugation of UCNPs with antibodies using the Particle Conjugation Kit (AnteoBind-Nano Kit for particles < 0.5 μm) proceeded according to the manufacturer's protocol (AnteoTech, Australia). The kit contains particle activation solution, particle wash solution, conjugation buffer at pH= 6, blocker diluent at pH= 6, and storage buffer at pH= 8.
as Morningstar describes Anteotech "The company is developing four products named AnteoX, Ultranode, AnteoBind NXT, and AnteoBind these products are used in the energy, diagnostic, and medical device markets." the uses of Anteo's technology IMO will see this product range expand as the company matures financially and technically and as a result the potential market of anteotech will increase from here where potential it is already significant.
GLTAH, DYOR, IMO etc etc. .....
